Hainan Huluwa Pharmaceutical Group Co (SHSE:605199) Total Stockholders Equity : ¥1,150 Mil (As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Hainan Huluwa Pharmaceutical Group Co Total Stockholders Equity?

Hainan Huluwa Pharmaceutical Group Co's Total Stockholders Equity for the quarter that ended in Mar. 2024 was ¥1,150 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Hainan Huluwa Pharmaceutical Group Co's Book Value per Share for the quarter that ended in Mar. 2024 was ¥2.87. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Hainan Huluwa Pharmaceutical Group Co's Debt-to-Equity for the quarter that ended in Mar. 2024 was 1.12.

Hainan Huluwa Pharmaceutical Group Co Total Stockholders Equity Historical Data

The historical data trend for Hainan Huluwa Pharmaceutical Group Co's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hainan Huluwa Pharmaceutical Group Co Total Stockholders Equity Chart

Hainan Huluwa Pharmaceutical Group Co Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Stockholders Equity

Get a 7-Day Free Trial

643.94

916.08

928.21

1,013.89

1,120.39

Hainan Huluwa Pharmaceutical Group Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Stockholders Equity	Get a 7-Day Free Trial															1,054.45	1,075.28	1,091.42	1,120.39	1,149.52

Hainan Huluwa Pharmaceutical Group Co (SHSE:605199) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Hainan Huluwa Pharmaceutical Group Co's Book Value per Share for the quarter that ended in Mar. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(1149.521	-	0)	/	400.109
	=	2.87

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Hainan Huluwa Pharmaceutical Group Co's Debt-to-Equity for the quarter that ended in Mar. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(741.696	+	545.493)	/	1149.521
	=	1.12

Hainan Huluwa Pharmaceutical Group Co Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Hainan Huluwa Pharmaceutical Group Co's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Hainan Huluwa Pharmaceutical Group Co (SHSE:605199) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hainan Huluwa Pharmaceutical Group Co Ltd (SHSE:605199) » Definitions » Total Stockholders Equity

Traded in Other Exchanges

N/A

Address

No. 8, Yaogu 4th Road, Phase II, Yaogu Industrial Park, Haikou National High-tech Zone, Hainan Province, Haikou, CHN, 570300

Website

http://www.huluwayaoye.com

Hainan Huluwa Pharmaceutical Group Co Ltd is engaged in production and sales of Chinese patent medicines and chemical drugs. The company produces medicines for children's respiratory and digestive systems. Its products include star products, calabash, gourd dad, and gourd mom.

Hainan Huluwa Pharmaceutical Group Co (SHSE:605199) Headlines

No Headlines